Accelsiors CRO
Boris Filichkin is a Clinical Research Associate at Accelsiors CRO since March 2022, with prior experience at CliniRx UK Limited from May 2020 to February 2022, where responsibilities included effective communication with principal investigators and training site staff. Boris held an Independent Translator/Interpreter position from December 2010 to February 2022, translating between Italian, Russian, and English. Additionally, Boris served as a Business Development Officer and Clinical Research Associate at Sintesi Research s.r.l. from May 2020 to March 2021, and as the Director of a pharmacy at Formula Zdorovja from July 2009 to May 2010, managing pharmacy operations and staff. Earlier experience includes a medical career with the Ministry of Defense in Russia from June 1994 to July 2008, treating military personnel and responding to disasters. Boris holds a PhD in Management in Medicine and a Doctor of Medicine degree from Smolensk State Medical Academy, along with specializations in Clinical Neurology and Clinical Psychiatry.
This person is not in any offices
Accelsiors CRO
1 followers
Accelsiors is a scientifically-driven, global, full-service Contract Research Organization (CRO). We support the Pharma industry globally to accelerate and manage every activity across clinical drug development. Since 2002, we have been committed to providing Sponsors working in highly complex disease indications with the scientific knowledge, regulatory expertise and quality operations necessary to achieve their development objectives. Accelsiors expertise includes studies in the following areas: • Biosimilars • Complex Generics • Endocrinology • Hepatology • Infectious Disease • Inflammatory Disease • Nephrology • Neurology • Oncology • Pulmonary • Rare Diseases • Rheumatology We serve a global Customer base, which ranges from emerging biotechnology companies to multi-national pharmaceutical companies. Accelsiors is committed to establishing meaningful collaborations with our Sponsors and executing studies, regardless of size and scope, with quality being the key driver in all that we do.